GNRH1 and prostate cancer: In ovarian, endometrial, mammary, and prostate cancers significant level of GNRH1 expression was also detected and the agonists of GNRH1 have been shown to inhibit proliferation and stimulate apoptosis of ovarian and endometrial carcinoma cells [37].